DM Clinical Research Receives 2022 Excellence in Patient Centricity Award
October 12, 2022 – Today the Society for Clinical Research Sites (SCRS) is pleased to announce the winner of the 2022 Excellence in Patient Centricity award, DM Clinical Research. The award, sponsored by Sanofi, was created to celebrate a clinical research site that places patient experience at the center of its operations.
DM Clinical Research won this year’s award by adopting patient-centricity as a measurable and strategic goal for its organization. They started by analyzing their patients’ journeys by communicating directly with trial participants, where they discovered redundancies, confusion and discontinuities in communication. Their team streamlined communication channels and made an effort to tailor to individual patients’ preferred mode (text, email, phone) and time to be contacted, and increased coverage hours to accommodate these preferences.
Additionally, they launched a Patient Advocates training program which ensured dedicated personnel at each site solely focused on patient satisfaction. This role included greeting patients, offering regular updates on wait times, and ensuring patient comfort. A patient survey was instituted that allowed their organization to establish a baseline, benchmark between sites and study teams, track progress over time, and continually solicit areas of improvement.
SCRS Global Impact Partners (GIPs) and sites cast their nominations for the award, which was eligible to any active SCRS member site. Through an independent judging panel, the winner was selected to receive the award at the SCRS Eagle Award Gala held during the SCRS Global Site Solutions Summit on Saturday, October 8, 2022.
“At DM Clinical Research our belief has always been to create systems and processes that are patient-centric and ensure that our core values are not just talked about but operationalized through measurable outcomes,” said Hera Arham, Director of Marketing and Patient Engagement at DM Clinical Research. “We’re incredibly grateful to have won this coveted award and are thankful to our staff, investigators, and most importantly our patients who have contributed to the development of a patient-centric culture through impactful feedback, reliable data, and metrics. We strive to keep patient-centricity at the forefront of all we do.”
“Putting patients first is something many industry organizations strive to do but can be challenging to implement. However, we saw many sites this year that went above and beyond to make clinical trials more accessible and convenient for their trial participants,” added Jimmy Bechtel, SCRS VP of Site Engagement. “SCRS applauds DM Clinical Research for their industry-leading initiatives that have improved the patient journey from start to finish. We are honored to help amplify the outstanding work they have done in providing a blueprint for successful patient-centric processes.”
For more information about the Excellence in Patient Centricity Award and the SCRS Global Site Solutions Summit, visit sitesolutionssummit.com.
About DM Clinical Research
DM Clinical is a network of clinical trial sites headquartered in Houston, Texas. Over the past 16 years, DMCR has grown to comprise 12 dedicated research centers and a network of affiliate sites throughout the nation, servicing a range of therapeutic areas, including vaccines, internal medicine, pediatrics, gastroenterology, psychiatry, women’s health, and more. DM Clinical has become a national leader in clinical research and has received industry recognition from the World Vaccine Congress as highly commended for Best Clinical Trial Site. Through its partnerships with prominent global pharmaceutical sponsors, DM Clinical brings opportunities to the community to participate in cutting-edge research, under the careful medical supervision of qualified physicians and professionals.
About
The Society for Clinical Research Sites
Founded in 2012, SCRS is a global organization that unifies the
voice of the clinical research site community to create greater site
sustainability. Representing over 9,500 sites in 47 countries, SCRS membership
provides sites with a community dedicated to advocacy, education, mentorship
and connectivity. SCRS is an influential voice for sites and an active partner
in industry-wide initiatives and dialogues focused on improving the clinical
research enterprise. Our Voice. Our Community. Your
Success. Join the community. Visit MySCRS.org.
Contact:
Marissa Hill
Communications Manager
Society for Clinical Research Sites
communications@myscrs.org
410.696.5080
